Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market sale Chief Executive Officer sold 15,186 shares at $6.22 ($94,428)
  2. 8-K Event Regulation FD disclosure
  3. UPLOAD Other SEC-generated Letter
  4. 4 Open-market sale Chief Medical Officer sold 5,383 shares at an average $8.47 ($45,612)
  5. 4 Open-market sale President and Head of R&D sold 10,124 shares at $8.32 ($84,216)
  6. 4 Open-market sale Chief Financial Officer sold 1,291 shares at $8.32 ($10,739)
  7. 4 Open-market sale Chief Executive Officer sold 5,849 shares at $8.32 ($48,651)
  8. S-3 Offering Registration Statement
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Option exercise Director acquired 2,000 shares (option exercise)
  20. SC 13G/A Stake Amended Statement of Ownership

Page 16 of 32 · 631 filings